Novel RET Fusion RET-SEPTIN9 Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant Pheochromocytoma. (2021)

Record Type:
Journal Article
Title:
Novel RET Fusion RET-SEPTIN9 Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant Pheochromocytoma. (2021)
Main Title:
Novel RET Fusion RET-SEPTIN9 Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant Pheochromocytoma
Authors:
Mweempwa, Angela
Xu, Huiling
Vissers, Joseph H. A.
Tothill, Richard W.
Pattison, Andrew D.
Fellowes, Andrew P.
Thomas, David M.
Richardson, Gary
Hicks, Rodney J.
Grimmond, Sean M.
Fox, Stephen B.
Luen, Stephen J.
Desai, Jayesh
Solomon, Benjamin J.
Abstract:
Is Part Of:
JCO precision oncology. Volume 5(2021)
Journal:
JCO precision oncology
Issue:
Volume 5(2021)
Issue Display:
Volume 5, Issue 2021 (2021)
Year:
2021
Volume:
5
Issue:
2021
Issue Sort Value:
2021-0005-2021-0000
Page Start:
Page End:
Publication Date:
2021
Subjects:
Precision Medicine
Neoplasms
Pharmacogenetics
Molecular Targeted Therapy
Personalized medicine
Oncology
Pharmacogenomics
Periodical
Periodicals
616.994
Journal URLs:
http://po.jco.org ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:
10.1200/PO.21.00127 ↗
Languages:
English
ISSNs:
2473-4284
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
22882.xml